News summary

OncoHost Presents New Research Revealing Biological Drivers of TKI Sensitivity in Metastatic Renal Cell Carcinoma at ESMO 2026

Source: PR Newswire • Published: 26 Oct 2026, 07:57

Summarized by Masters of Longevity from PR Newswire.

Pretreatment plasma proteins were tied to pathways linked with TKI sensitivity.

OncoHost Presents New Research Revealing Biological Drivers of TKI Sensitivity in Metastatic Renal Cell Carcinoma at ESMO 2026
Key Takeaways
  • Plasma proteomics showed links to angiogenesis and vascular remodeling.
  • Model was developed and validated in treated metastatic renal cell carcinoma.
  • Clinical association remains observational and does not prove causality.
Read the full article at PR Newswire ↗

Continue exploring

Recommended MoL Picks

MoL PickCan You Really Measure Whether You’re Aging More Slowly?A younger epigenetic-age score can look like proof that an intervention is working. A major new analysis shows which clocks detect change—and why movement is not yet the same as longer healthspan.MoL PickBiotin for Hair Growth: The Weak Evidence—and the Blood-Test Risk Most People MissBiotin deficiency can affect hair. That does not mean more biotin makes healthy hair grow—and high doses can distort important laboratory results.MoL PickPlan Your Health Tests in Three MinutesThe free Personal Health Diagnostics Planner turns a short questionnaire into a ranked, personalised PDF: a clearer starting point for deciding which health checks deserve attention now.